Optimised Pacing Program

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 1793 participants.

Also called NCT01819662

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose diagnostic
Phase
Phase 3
Enrolled
  • 1,793 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01819662
Other papers using this trial's data
  • Echocardiographic screening for heart failure and optimization of the care pathway for individuals with pacemakers: a randomized controlled trial Nature medicine, 2024-11 DOI, PubMed 39300290, PMC11564098 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01819662. Randomized; double masking; primary purpose diagnostic. Start 2013-08-01 (actual); primary completion 2017-10-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Optimised Pacing Program
Acronym
OPT-pace
Condition
Pacemaker Complication
Condition
Congestive Heart Failure
Intervention (Other)
Enhanced standard management
Intervention (Other)
Optimised heart failure management
Intervention (Other)
Standard management
Lead sponsor
University of Leeds (class: other)
Collaborator
National Institute for Health Research, United Kingdom (class: other government)

Record details

Record id
cardio:ct-nct01819662
Content hash
b85d481a76b955eb270ed8e109a3d56fa50b059f5ce9e3e0036249fd0b928383